JOHN S GREENSPAN
University of California San Francisco, CA, USAAlmost
28 years since the first reports of what soon became known as the acquired
immunodeficiency syndrome [AIDS] and 26 years since the identification of
its cause, LAV, subsequently called the human immunodeficiency virus [HIV],
the pandemic continues to grow, slowed somewhat by prevention, sophisticated
diagnostics and multiple treatment approaches. We have gained many insights
into the zoonotic origin of HIV, its transmission, host responses
contributing to resistance, pathogenic effects on the host, sites and nature
of latent infection, viral treatment targets and responses to therapeutic
agents. The demographics of the 33 million living affected people vary
dramatically by location, as does the extent of antiretroviral therapy [ART]
availability. ART has been tremendously effective in prolonging life,
improving quality of life and reducing mortality. Behavioral prevention
approaches, combined with early diagnosis, measures such as male
circumcision and widespread availability of monitored therapy are key to
emerging hope for stemming the tide until, hopefully and perhaps
optimistically, an effective vaccine becomes available. |